BRIEF published on 11/14/2025 at 15:35, 4 months 12 days ago Grünenthal Expands Bond Offering by €175 Million Financial Results Pharmaceutical Debt Issuance Grünenthal Bond Extension
PRESS RELEASE published on 11/14/2025 at 15:30, 4 months 12 days ago Grünenthal announces pricing of bond extension Grünenthal extends Senior Secured Notes by €175 million to a total of €675 million with 4.625% interest rate and maturity in 2031 Pharmaceutical Company Senior Secured Notes Grünenthal Debt Issue Bond Extension
BRIEF published on 03/27/2025 at 09:36, 11 months 30 days ago Grünenthal Reports Strong 2024 Financial Results Financial Results Strategic Growth US Market Expansion Grünenthal 2024 Valinor Acquisition
PRESS RELEASE published on 03/27/2025 at 09:31, 11 months 30 days ago Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US Grünenthal reports exceptional 2024 financial results driven by strategic growth and Valinor acquisition in the US Financial Results 2024 Strategic Growth Grünenthal Valinor Acquisition
BRIEF published on 12/06/2024 at 13:22, 1 year 3 months ago Grünenthal Successfully Issues €500 Million Bond Bond Issuance Grünenthal Maturity Profile €500 Million Finance Strategy
PRESS RELEASE published on 12/06/2024 at 13:17, 1 year 3 months ago Grünenthal successfully places new €500 million bond Grünenthal GmbH successfully places new €500 million bond to strengthen capital structure and pursue growth strategy, enhancing flexibility for investments and innovation Growth Strategy Bond Capital Structure Debt Issue Grünenthal GmbH
BRIEF published on 11/27/2024 at 09:40, 1 year 3 months ago Grünenthal Announces €500 Million Bond Pricing Bond Issuance Credit Ratings Debt Refinancing €500 Million Grünenthal GmbH
PRESS RELEASE published on 11/27/2024 at 09:35, 1 year 3 months ago Grünenthal announces pricing of €500 million bond Grünenthal GmbH announces pricing of €500 million bond to enhance capital structure and maturity profile. New financing to refinance existing debt and repurchase outstanding notes Bond Finance Debt Pricing Grünenthal GmbH
BRIEF published on 03/25/2024 at 09:35, 2 years ago Grünenthal Announces Strong Financial Results for 2023 with Continued Focus on R&D and Strategic Acquisitions Pharmaceuticals Annual Results Strategic Acquisitions Grünenthal R&D Investment
PRESS RELEASE published on 03/25/2024 at 09:30, 2 years ago Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Grünenthal reports strong 2023 results with record revenue and continued investments in R&D and acquisitions Acquisitions 2023 Results Record Revenue R&D Investments Grünenthal
Published on 03/26/2026 at 16:20, 22 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 3 hours 42 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 3 hours 42 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 3 hours 43 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 16:20, 21 minutes ago Sartorius AG Supervisory Board extends appointment of board member René Fáber
Published on 03/26/2026 at 15:25, 1 hour 17 minutes ago Duck Creek Loss Control Named 2026 Insurance Luminary Finalist by PropertyCasualty360
Published on 03/26/2026 at 15:23, 1 hour 19 minutes ago Sartorius AG - Resolutions of the Annual General Meeting
Published on 03/26/2026 at 15:05, 1 hour 37 minutes ago JOY GROUP Announces 2025 Financial Results, Revenue Surpasses US$620M
Published on 03/26/2026 at 15:01, 1 hour 40 minutes ago EQS-Adhoc: CENIT AG decides to switch from the Regulated Market (Prime Standard) to the Scale Segment of the Frankfurt Stock Exchange
Published on 03/26/2026 at 07:30, 9 hours 12 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 22 hours 11 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 22 hours 57 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
